Management Team . . Board of Directors . . Investors . . Advisors

Meet our Management Team

Kim Albizati, Ph.D. - Co-founder and Chief Executive Officer

Prior to co-founding BioVerdant, Dr. Albizati was Executive Director of Chemical Research and Development in Pfizer Global R&D in La Jolla, CA. While at Pfizer Dr. Albizati built and led a 70-person Chemical R&D group with capabilities in process development, chemical engineering, automation and robotics, high-throughput screening, computational chemistry and intermediate scale drug production. Beginning in the late 1990’s he created (with co-founder Alex Tao) the first dedicated group in the pharmaceutical industry to use enzymatic biotransformations in chemical process development. This group gained an international reputation in the industry and in academic circles for its innovations in high-throughput enzyme screening, solvent effects in enzyme chemistry and manufacturing process development. Dr. Albizati began his industrial chemistry career in 1993 starting in the early days of Agouron Pharmaceuticals, a San Diego area biotech success story, and stayed with Agouron through the Warner-Lambert and Pfizer mergers.

Dr. Albizati obtained a Ph.D. in Organic Chemistry at UCLA working with the classical alkaloid chemist R.V. Stevens. He performed postdoctoral work in the chemistry of the marine environment at the Scripps Institution of Oceanography in the labs of John Faulkner. He moved from Scripps to the Department of Chemistry at Wayne State University where he built a nationally-funded, diverse research group and rose to the rank of tenured Associate Professor of Chemistry. He left Wayne State in 1992 to return to California, taking a visiting professor position at the University of California, San Diego. He taught a variety of chemistry courses until 1997, receiving the Revelle College Faculty Teaching Award in 1995 and 1997. Dr. Albizati has co-authored over 50 publications including two books and several book chapters, review articles and is a named inventor on numerous patents.

kim.albizati@bioverdant.com